rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2001-5-4
|
pubmed:abstractText |
Despite the increased use of statistical mapping to detect brain functional changes in Alzheimer's disease (AD), potential artifacts introduced by stereotactic anatomic standardization of atrophied brains have not been examined carefully. We investigated the effects of anatomic standardization by Statistical Parametric Mapping (SPM) and NEUROSTAT.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0161-5505
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
548-57
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11337540-Aged,
pubmed-meshheading:11337540-Alzheimer Disease,
pubmed-meshheading:11337540-Atrophy,
pubmed-meshheading:11337540-Brain,
pubmed-meshheading:11337540-Brain Mapping,
pubmed-meshheading:11337540-Female,
pubmed-meshheading:11337540-Fluorodeoxyglucose F18,
pubmed-meshheading:11337540-Glucose,
pubmed-meshheading:11337540-Humans,
pubmed-meshheading:11337540-Image Processing, Computer-Assisted,
pubmed-meshheading:11337540-Magnetic Resonance Imaging,
pubmed-meshheading:11337540-Male,
pubmed-meshheading:11337540-Middle Aged,
pubmed-meshheading:11337540-Radiopharmaceuticals,
pubmed-meshheading:11337540-Reference Values,
pubmed-meshheading:11337540-Software Validation,
pubmed-meshheading:11337540-Tomography, Emission-Computed
|
pubmed:year |
2001
|
pubmed:articleTitle |
Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
|
pubmed:affiliation |
Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, München, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't,
Validation Studies
|